Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

ClinicalTrials.gov ID: NCT00124982

Public ClinicalTrials.gov record NCT00124982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 18, 2026, 2:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multi-Center, Open Label Study to Evaluate the Efficacy, Tolerability and Safety of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDs Who Have an Inadequate Response to Anti-TNF Therapy and Have Limited Therapeutic Options

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to summarize the safety and tolerability of abatacept during 6 months of combined treatment with one or more of the background non-biologic disease modifying anti-rheumatic drugs (DMARDs) approved for rheumatoid arthritis (RA) in subjects with active RA. Secondary objectives assessed the clinical efficacy of combination treatment, including disease activity, physical function, and quality of life outcomes.

Study identification

NCT ID
NCT00124982
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,286 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2005
Primary completion
Jul 31, 2009
Completion
Jul 31, 2009
Last update posted
Feb 26, 2012

2005 – 2009

United States locations

U.S. sites
114
U.S. states
35
U.S. cities
114
Facility City State ZIP Site status
Local Institution Birmingham Alabama
Local Institution Huntsville Alabama
Local Institution Paradise Valley Arizona
Local Institution Peoria Arizona
Local Institution Tucson Arizona
Local Institution Long Beach California
Local Institution Palm Springs California
Local Institution Palo Alto California
Local Institution San Diego California
Local Institution Santa Monica California
Local Institution Colorado Springs Colorado
Local Institution Denver Colorado
Local Institution Danbury Connecticut
Local Institution Hamden Connecticut
Local Institution Trumbull Connecticut
Local Institution Washington D.C. District of Columbia
Local Institution Aventura Florida
Local Institution Clearwater Florida
Local Institution Fort Lauderdale Florida
Local Institution Jupiter Florida
Local Institution Largo Florida
Local Institution Sarasota Florida
Local Institution Atlanta Georgia
Local Institution Blue Ridge Georgia
Local Institution Macon Georgia
Local Institution Morton Grove Illinois
Local Institution Evansville Indiana
Local Institution Indianapolis Indiana
Local Institution Des Moines Iowa
Local Institution Kansas City Kansas
Local Institution Prairie Village Kansas
Local Institution Bowling Green Kentucky
Local Institution Louisville Kentucky
Local Institution New Orleans Louisiana
Local Institution Boston Massachusetts
Local Institution Peabody Massachusetts
Local Institution Springfield Massachusetts
Local Institution Worcester Massachusetts
Local Institution Ann Arbor Michigan
Local Institution East Lansing Michigan
Local Institution Grand Rapids Michigan
Local Institution Lansing Michigan
Local Institution Petockey Michigan
Local Institution Minneapolis Minnesota
Local Institution Saint Paul Minnesota
Local Institution Omaha Nebraska
Local Institution Las Vegas Nevada
Local Institution Lebanon New Hampshire
Local Institution Nashua New Hampshire
Local Institution Cherry Hill New Jersey
Local Institution Dover New Jersey
Local Institution Manalapan New Jersey
Local Institution New Brunswick New Jersey
Local Institution Somerset New Jersey
Local Institution Teaneck New Jersey
Local Institution Voorhees Township New Jersey
Local Institution Albany New York
Local Institution Brooklyn New York
Local Institution Hewlett New York
Local Institution Lake Success New York
Local Institution Mineola New York
Local Institution New York New York
Local Institution Olean New York
Local Institution Orchard Park New York
Local Institution Rochester New York
Local Institution Schenectady New York
Local Institution Smithtown New York
Local Institution Syracuse New York
Local Institution Asheville North Carolina
Local Institution Charlotte North Carolina
Local Institution Hickory North Carolina
Local Institution Wilmington North Carolina
Local Institution Bismarck North Dakota
Local Institution Akron Ohio
Local Institution Beachwood Ohio
Local Institution Cleveland Ohio
Local Institution Columbus Ohio
Local Institution Mayfield Village Ohio
Local Institution Youngstown Ohio
Local Institution Portland Oregon
Local Institution Bala-Cynwyd Pennsylvania
Local Institution Bethlehem Pennsylvania
Local Institution Camp Hill Pennsylvania
Local Institution Duncansville Pennsylvania
Local Institution Erie Pennsylvania
Local Institution Meadville Pennsylvania
Local Institution Philadelphia Pennsylvania
Local Institution Pittsburgh Pennsylvania
Local Institution West Reading Pennsylvania
Local Institution Wexford Pennsylvania
Local Institution Willow Grove Pennsylvania
Local Institution Providence Rhode Island
Local Institution Myrtle Beach South Carolina
Local Institution Simpsonville South Carolina
Local Institution Sioux Falls South Dakota
Local Institution Hixson Tennessee
Local Institution Knoxville Tennessee
Local Institution Austin Texas
Local Institution Corpus Christi Texas
Local Institution Dallas Texas
Local Institution Galveston Texas
Local Institution Houston Texas
Local Institution Lubbock Texas
Local Institution San Antonio Texas
Local Institution Sugarland Texas
Local Institution Burke Virginia
Local Institution Chesapeake Virginia
Local Institution Fairfax Virginia
Local Institution Salem Virginia
Local Institution Seattle Washington
Local Institution Vancouver Washington
Local Institution Glendale Wisconsin
Local Institution La Crosse Wisconsin
Local Institution Madison Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00124982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2012 · Synced Sep 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00124982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →